Attend the Terrapinn's 5th annual antibody and antibody alternative event this September 21-25,2009 at Hamilton Crowne Plaza, Washington DC.
Americas Antibody Congress is THE forum for senior-level executives in the biotech & pharmaceutical industries to gather together to discuss this soon-to-be $30 billion industry.
Americas Antibody Congress will focus on issues in regulation and clinical trials, determining immunogenicity, successfully identifying lead candidates, advancing your knowledge of optimal production and manufacturing, developing next-generation antibody products and identifying the future therapeutic targets for antibody development.
Americas Antibody Congress is an interactive platform where innovations are discussed, best practices are shared, and partnership opportunities are sealed.
Key topics
* The pharmaceutical industry landscape
* Identifying antibody targets
* Non-activating antibody formats
* Strategies to minimize immunogenicity
* De novo selection of high affinity antibodies
* Tailoring antibodies to enhance target site distribution
* Enhancing effector function
* Bi-specific antibodies
* Antibody drug conjugate development
* Next generation biologics
* Regulatory & approval process updates for monoclonal antibodies and biologics
* Follow on and second generation biologics
For more information please contact:
Michael Weinberg
Tel: 212 379 6320
Fax: 212 379 6319
michael.weinberg@terrapinn.com
or visit their website
0 comments
Post a Comment